Dashboard
Manage Tickers

DAREDare Bioscience, Inc.


$ 3.49 $ 0.04 (1.17 %)    

Monday, 09-Sep-2024 10:51:10 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 3.46
$ 3.37
$ 3.34 x 105
-- x --
$ 3.37 - $ 3.49
$ 3.05 - $ 7.56
11,251
na
29.57M
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dar-bioscience-announces-publication-in-the-journal-of-sexual-medicine-safety-findings-from-the-phase-2b-respond-clinical-study-of-sildenafil-cream-36
Daré Bioscience Announces Publication In T...
08/26/2024 12:13:33

Published data show that topical Sildenafil Cream, 3.6% was safe and well tolerated by women and their partners across 1,357 se...

maxim-group-downgrades-dare-bioscience-to-hold
Maxim Group Downgrades Dare Bioscience to ...
08/14/2024 16:21:57

Maxim Group analyst Caroline Palomeque downgrades Dare Bioscience (NASDAQ:DARE) from Buy to Hold.

dar-bioscience-announces-publication-in-the-journal-of-sexual-medicine-of-findings-from-the-phase-2b-respond-clinical-study-of-sildenafil-cream-36
Daré Bioscience Announces Publication In T...
08/13/2024 12:22:18

Published data show that responses from 1-month and 24-hour recall patient reported outcome (PRO) instruments were similar and ...

dare-bioscience-q2-2024-gaap-eps-152-sales-22438m
Dare Bioscience Q2 2024 GAAP EPS $1.52, Sa...
08/12/2024 20:31:59

Dare Bioscience (NASDAQ:DARE) reported quarterly earnings of $1.52 per share. The company reported $22.438 million in sales th...

dar-bioscience-regains-compliance-with-nasdaq-minimum-bid-price-rule
Daré Bioscience Regains Compliance With Na...
07/19/2024 12:02:09

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in innovation for the health and wellbeing of women, announced that it was notif...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
07/01/2024 12:55:05

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/28/2024 23:50:04

dar-bioscience-announces-1-for-12-reverse-stock-split-to-begin-trading-on-a-split-adjusted-basis-when-the-market-opens-on-monday-july-1-2024
Daré Bioscience Announces 1-For-12 Reverse...
06/27/2024 12:11:58

Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- Daré Biosc...

dar-bioscience-announces-publication-of-phase-2b-study-efficacy-results-of-topical-sildenafil-cream-36-for-the-treatment-of-female-sexual-arousal-disorder-in-obstetrics--gynecology
Daré Bioscience Announces Publication Of P...
06/24/2024 12:01:07

Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (F...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/30/2024 16:31:20

why-james-hardie-industries-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why James Hardie Industries Shares Are Tra...
05/21/2024 17:36:28

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 16:31:03

bayer-highlights-detailed-data-from-twin-late-stage-trials-on-experimental-menopause-candidate-seeks-regulatory-approval
Bayer Highlights Detailed Data From Twin L...
05/17/2024 15:02:25

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe men...

hc-wainwright--co-reiterates-buy-on-dare-bioscience-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Dare...
05/15/2024 14:43:49

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $6 price target.

brookline-capital-upgrades-dare-bioscience-to-buy-announces-3-price-target
Brookline Capital Upgrades Dare Bioscience...
05/15/2024 10:13:28

Brookline Capital analyst Kemp Dolliver upgrades Dare Bioscience (NASDAQ:DARE) from Hold to Buy and announces $3 price target.

dare-bioscience-q1-eps-007-misses-006-estimate
Dare Bioscience Q1 EPS $(0.07) Misses $(0....
05/14/2024 12:27:31

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0...

dare-bioscience-files-for-common-stock-offering-of-up-to-181m
Dare Bioscience Files For Common Stock Off...
05/10/2024 20:31:04

-SEC Filing

dar-bioscience-selected-as-a-member-of-arpa-h-investor-catalyst-hub-spoke-network
Daré Bioscience Selected As A Member Of AR...
05/02/2024 12:10:11

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it was selected as a spoke for ...

hc-wainwright--co-reiterates-buy-on-dare-bioscience-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Dare...
05/01/2024 11:12:58

HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $6 price target.

why-he-equipment-services-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why H&E Equipment Services Shares Are Trad...
04/30/2024 17:24:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION